Testing for thrombophilias

Clinical Advances in Hematology and Oncology

Volumn 6, Issue 9, 2008, Pages 646-649

  Moll, Stephan ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; ANTIVITAMIN K; BETA2 GLYCOPROTEIN 1 ANTIBODY; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; HEPARIN; HOMOCYSTEINE; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S; PROTHROMBIN;

ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING TEST; CLINICAL DECISION MAKING; EVIDENCE BASED PRACTICE; GENETIC POLYMORPHISM; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; LABORATORY TEST; PATIENT EDUCATION; PATIENT SELECTION; PRACTICE GUIDELINE; THROMBOPHILIA; THROMBOSIS; VENOUS THROMBOEMBOLISM;

FACTOR V; HEMATOLOGIC TESTS; HEPARIN; HUMANS; THROMBOPHILIA;

EID: 54949151114     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Moll S. Thrombophilias: practical implications and testing caveats. J Thromb Thrombolysis. 2006;21:7-15.
2. Grody WW, Griffia JH, Taylor AK, Korf BR, Heit JA; ACMG Factor V. Leiden Working Group. American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med. 2001;3:139-148.
3. Haemostatis and Thrombosis Task Force, British Committee for Standards in Haematology. Investigation and management of heritable thrombophilia. Br J Haematol. 2001;114:512-528.
4. The European Genetics Foundation; The Cardiovascular Disease Educational and Research Trust; The International Union of Angiology; The Mediterranean League on Thromboembolism, Nicolaides AN, Breddin HK, Carpenter P, et al. Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. Int Angiol. 2005;24:1-26
5. Mant M. Hypercoagulable/thrombophilic states. 2006. Available online: http://www.tigc.org/eguidelines/hypercoagstates.htm. Accessed September 2, 2008.